Cover Image

Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer

Background This meta-analysis seeks to assess the efficacy and safety of pembrolizumab in individuals with advanced or recurrent cervical cancer.Methods Databases from PubMed, Embase, and the Cochrane Library were all thoroughly searched for pertinent research. Outcomes include complete response (CR...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xue Zhang (Author), Wen-Jie Yin (Author), Ai-Li Zhang (Author), Xiao-Xiao Zhang (Author), Li-Juan Ding (Author), Jiao Zhang (Author), Shu-Ting He (Author), Jie-Ping Yan (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Complete remission of advanced and recurrent cervical cancer with pembrolizumab treatment- 3 case reports
by: Hsiu-Jung Tung, et al.
Published: (2021)

Pattern of disease and response to pembrolizumab in recurrent cervical cancer
by: Kathryn M. Miller, et al.
Published: (2021)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
by: Jonathan T. Hunt, et al.
Published: (2021)

Recurrent pembrolizumab-induced mechanical small bowel obstruction in a patient with metastatic cervical cancer
by: Sha Sha, et al.
Published: (2024)

A comprehensive bibliometric analysis (2000-2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer
by: Yuanqiong Duan, et al.
Published: (2024)

Spotlight on pembrolizumab in the treatment of advanced melanoma
by: Rajakulendran T, et al.
Published: (2015)

Lenvatinib and pembrolizumab versus platinum doublet chemotherapy as second-line therapy for advanced or recurrent endometrial cancer
by: Yutaka Yoneoka, et al.
Published: (2024)

Lenvatinib and pembrolizumab in patients with advanced uterine cancer
by: A. G. Kedrova, et al.
Published: (2021)

Efficacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients
by: Da Huang, et al.
Published: (2022)

The Influence of a School Social Network Intervention on Adolescent's Health Behaviors: A Gender-Specific Agent-Based Model
by: Shu Zhang, et al.
Published: (2022)

Cost-Effectiveness Analysis of Pembrolizumab in Patients With Advanced Esophageal Cancer Based on the KEYNOTE-181 Study
by: Mei Zhan, et al.
Published: (2022)

Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
by: N.Y.L. Ngoi, et al.
Published: (2018)

Safety profiles of Tripterygium wilfordii Hook F: a systematic review and meta-analysis
by: Chi Zhang, et al.
Published: (2016)

The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study
by: Yu J, et al.
Published: (2019)

Elevated Tristetraprolin Impairs Trophoblast Invasion in Women with Recurrent Miscarriage by Destabilization of HOTAIR
by: Fu-Ju Tian, et al.
Published: (2018)

Chemotherapy for advanced or recurrent cervical cancer
by: Toshiharu Kamura, et al.
Published: (2013)

Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
by: Blair McNamara, et al.
Published: (2023)

Retraction Notice to: Elevated Tristetraprolin Impairs Trophoblast Invasion in Women with Recurrent Miscarriage by Destabilization of HOTAIR
by: Fu-Ju Tian, et al.
Published: (2022)

Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
by: Åse Bratland, et al.
Published: (2023)

Case Report: Pediatric Recurrent Acute Liver Failure Caused by Neuroblastoma Amplified Sequence (NBAS) Gene Mutations
by: Bingxin Jiang, et al.
Published: (2021)

Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer in China
by: Zhang X, et al.
Published: (2023)

Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China-a 10-year continuous single-center study
by: Xue-Xiao Bai, et al.
Published: (2020)

Efficacy and safety of traditional Chinese medicine for the treatment of pancreatic cancer: An overview of systematic reviews and meta-analyses
by: Jing Wang, et al.
Published: (2022)

Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer
by: John K. Chan, et al.
Published: (2020)

The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis
by: Chunmei Zhang, et al.
Published: (2022)

Cost-effectiveness analysis of pembrolizumab versus targeted therapies in advanced melanoma
by: E. G. Kosolapov, et al.
Published: (2018)

Relationships between nine neuropsychiatric disorders and cervical cancer: insights from genetics, causality and shared gene expression patterns
by: Jie Li, et al.
Published: (2024)

Cost-effectiveness of maintenance niraparib with an individualized starting dosage in patients with platinum-sensitive recurrent ovarian cancer in China
by: Yin Shi, et al.
Published: (2023)

The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma
by: Risako Ozawa, et al.
Published: (2024)

Huisheng Oral Solution Adjunct With Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review
by: Jingyi Huang, et al.
Published: (2020)

Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease
by: He Li, et al.
Published: (2018)

Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: A case series
by: Shannon M. Glynn, et al.
Published: (2024)

Advanced Merkel cell carcinoma in setting of pembrolizumab therapy for squamous cell carcinoma
by: Henry Jeon, BSc, et al.
Published: (2024)

Lenvatinib Plus Pembrolizumab vs. Chemotherapy in Pretreated Patients With Advanced Endometrial Cancer: A Cost-Effectiveness Analysis
by: Mingyang Feng, et al.
Published: (2022)

COVID-19 impacts on cross-border mobility of senior population between Shenzhen and Hong Kong
by: Shi He, et al.
Published: (2023)

Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
by: Bing Li, et al.
Published: (2020)

Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer
by: Kaito Mimura, et al.
Published: (2022)

Research advances on congenital solitary functioning kidney in children
by: Bing-jie Cheng, et al.
Published: (2024)

Assessment of serum malondialdehyde, uric acid, and vitamins C and E levels in patients with recurrent aphthous stomatitis
by: Xiao-Yan Li, et al.
Published: (2016)

Salvia-Nelumbinis Naturalis Formula Improved Inflammation in LPS Stressed Macrophages via Upregulating MicroRNA-152
by: Zansong Ma, et al.
Published: (2017)